BioRestorative Therapies Company Profile (NASDAQ:BRTX)

About BioRestorative Therapies (NASDAQ:BRTX)

BioRestorative Therapies logoBioRestorative Therapies, Inc. develops therapeutic products and medical therapies using cell and tissue protocols, involving adult (non-embryonic) stem cells. The Company offers human and plant stem cell derived cosmetic and skin care products. Its programs relate to the treatment of disc/spine disease and metabolic disorders and include Disc/Spine Program (brtxDISC) and Metabolic Program (ThermoStem). Its curved needle device (CND) is a needle system with a curved inner cannula to allow access to difficult-to-locate regions for the delivery or removal of fluids and other substances. The CND is intended to deliver stem cells and/or other therapeutic products or material to the interior of a human intervertebral disc, the spine region, or other areas of the body. The device relies on the use of pre-curved nested cannulae that allows the cells or material to be deposited in the posterior and lateral aspects of the disc to which direct access is not possible due to outlying structures.

Industry, Sector and Symbol: Average Prices:
  • 50 Day Moving Avg: $3.34
  • 200 Day Moving Avg: $3.65
  • 52 Week Range: $2.70 - $5.01
P/E:
  • Trailing P/E Ratio: N/A
  • P/E Growth: 0.00
Sales & Book Value:
  • Annual Revenue: $38,075.00
  • Price / Sales: N/A
  • Book Value: ($1.04) per share
  • Price / Book: -2.98
Profitability:
  • EBIDTA: ($8,380,000.00)
  • Net Margins: -13,735.90%
  • Return on Assets: -758.82%
Misc:
  • Average Volume: 1,178 shs.
 

Frequently Asked Questions for BioRestorative Therapies (NASDAQ:BRTX)

What is BioRestorative Therapies' stock symbol?

BioRestorative Therapies trades on the NASDAQ under the ticker symbol "BRTX."

Who are some of BioRestorative Therapies' key competitors?

Who are BioRestorative Therapies' key executives?

BioRestorative Therapies' management team includes the folowing people:

  • Mark Weinreb, Chairman of the Board, President, Chief Executive Officer
  • Robert B. Catell, Independent Director
  • John M. Desmarais, Independent Director
  • A. Jeffrey Radov, Independent Director
  • Paul Jude Tonna, Independent Director

How do I buy BioRestorative Therapies stock?

Shares of BioRestorative Therapies can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is BioRestorative Therapies' stock price today?

One share of BioRestorative Therapies stock can currently be purchased for approximately $3.10.


MarketBeat Community Rating for BioRestorative Therapies (NASDAQ BRTX)
Community Ranking:  2.9 out of 5 (star star)
Outperform Votes:  16 (Vote Outperform)
Underperform Votes:  12 (Vote Underperform)
Total Votes:  28
MarketBeat's community ratings are surveys of what our community members think about BioRestorative Therapies and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Consensus Ratings for BioRestorative Therapies (NASDAQ:BRTX) (How are Consensus Ratings Calculated?)
Ratings Breakdown: No ratings tracked in the last 12 months.
Consensus Rating:N/A (Score: NaN)
Consensus Price Target: N/A

Analysts' Ratings History for BioRestorative Therapies (NASDAQ:BRTX)
Show:
No equities research coverage for this company has been tracked by MarketBeat.com

Earnings

Earnings History for BioRestorative Therapies (NASDAQ:BRTX)
No earnings announcements for this company have been tracked by MarketBeat.com

Estimates

Earnings Estimates for BioRestorative Therapies (NASDAQ:BRTX)

No earnings estimates for this company have been tracked by MarketBeat.com

Dividends

Dividend History for BioRestorative Therapies (NASDAQ:BRTX)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading and Institutional Ownership History for BioRestorative Therapies (NASDAQ:BRTX)
Insider Trades by Quarter for BioRestorative Therapies (NASDAQ:BRTX)
Insider Trades by Quarter for BioRestorative Therapies (NASDAQ:BRTX)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
9/26/2016John M DesmaraisDirectorBuy80,000$3.00$240,000.00View SEC Filing  
5/18/2016Robert B CatellDirectorBuy12,500$4.00$50,000.00View SEC Filing  
3/18/2016John M DesmaraisDirectorBuy250,000$4.00$1,000,000.00View SEC Filing  
3/1/2016Robert B CatellDirectorBuy37,500$4.00$150,000.00View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Headline Trends for BioRestorative Therapies (NASDAQ:BRTX)
Latest Headlines for BioRestorative Therapies (NASDAQ:BRTX)
Source:
DateHeadline
finance.yahoo.com logoBioRestorative Therapies, Inc. :BRTX-US: Earnings Analysis: Q2, 2017 By the Numbers : August 16, 2017
finance.yahoo.com - August 16 at 5:16 PM
finance.yahoo.com logoBioRestorative Therapies to Present at 6th Annual Marcum MicroCap Conference
finance.yahoo.com - June 14 at 4:43 PM
finance.yahoo.com logoBioRestorative Therapies, Inc. :BRTX-US: Earnings Analysis: Q1, 2017 By the Numbers : May 24, 2017
finance.yahoo.com - May 24 at 12:57 PM
biz.yahoo.com logoBIORESTORATIVE THERAPIES, INC. Files SEC form 8-K, Unregistered Sale of Equity Securities, Change in Directors or Pri
biz.yahoo.com - February 14 at 9:42 PM
biz.yahoo.com logoBIORESTORATIVE THERAPIES, INC. Files SEC form 8-K, Unregistered Sale of Equity Securities
biz.yahoo.com - February 8 at 4:16 PM
finance.yahoo.com logoBioRestorative Therapies Receives FDA Clearance to Initiate Phase 2 Clinical Trial for the Treatment of Patients with Degenerative Disc Disease
finance.yahoo.com - February 8 at 4:16 PM
us.rd.yahoo.com logo9:46 am BioRestorative Therapies submits an Investigational New Drug Application to the FDA to seek clearance to commence a clinical trial using its lead cell therapy candidate, BRTX-100, to treat chronic lower back pain due to degenerative
us.rd.yahoo.com - January 9 at 10:09 PM
biz.yahoo.com logoBIORESTORATIVE THERAPIES, INC. Files SEC form 8-K, Submission of Matters to a Vote of Security Holders
biz.yahoo.com - October 20 at 8:51 PM
globenewswire.com logoNo Adverse Events and Overall Improvement Reported by Study Patients
globenewswire.com - September 13 at 8:49 AM
finance.yahoo.com logoBioRestorative Therapies Announces Publication in Medical Journal of Positive Results of Long-Term Safety and Feasibility Study Using Cell Therapy to Treat Patients with Degenerative Disc Disease
finance.yahoo.com - September 12 at 3:51 PM
finance.yahoo.com logo9:46 am BioRestorative Therapies announces publication in Medical Journal of results of long-term safety and feasibility study using cell therapy to treat patients with degenerative disc disease
finance.yahoo.com - September 12 at 3:51 PM
finance.yahoo.com logoBioRestorative Therapies Announces Presentation at 3rd Annual Regenerative Medicine Essentials Course
finance.yahoo.com - July 13 at 10:47 AM
biz.yahoo.com logoBIORESTORATIVE THERAPIES, INC. Files SEC form 8-K, Creation of a Direct Financial Obligation or an Obligation under a
biz.yahoo.com - June 30 at 4:36 PM
finance.yahoo.com logoBioRestorative Therapies Announces Completion of Human Safety and Feasibility Study on the Use of Hypoxic Cultured Stem Cells to Treat Chronic Lower Back Pain
finance.yahoo.com - June 28 at 9:45 AM
biz.yahoo.com logoBIORESTORATIVE THERAPIES, INC. Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits
biz.yahoo.com - June 2 at 6:02 AM
finance.yahoo.com logoBioRestorative Therapies to Present at 5th Annual Marcum MicroCap Conference
finance.yahoo.com - May 31 at 9:45 AM
finance.yahoo.com logoBioRestorative Therapies Announces Promising Data to Advance its Program for the Treatment of Metabolic Disorders
finance.yahoo.com - May 23 at 9:45 AM
biz.yahoo.com logoBIORESTORATIVE THERAPIES, INC. Files SEC form 10-Q, Quarterly Report
biz.yahoo.com - May 13 at 5:39 PM
biz.yahoo.com logoBIORESTORATIVE THERAPIES, INC. Files SEC form 10-K, Annual Report
biz.yahoo.com - March 30 at 5:35 PM
biz.yahoo.com logoBIORESTORATIVE THERAPIES, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Unregistered Sale of E
biz.yahoo.com - March 24 at 11:55 AM
biz.yahoo.com logoBIORESTORATIVE THERAPIES, INC. Files SEC form 8-K, Change in Directors or Principal Officers, Other Events, Financial
biz.yahoo.com - February 24 at 1:53 PM
biz.yahoo.com logoBIORESTORATIVE THERAPIES, INC. Files SEC form 8-K, Submission of Matters to a Vote of Security Holders, Change in Dir
biz.yahoo.com - December 28 at 11:22 AM
finance.yahoo.com logoBioRestorative Therapies Provides Company Updates With Shareholder Letter
finance.yahoo.com - December 21 at 8:00 AM
finance.yahoo.com logoBIORESTORATIVE THERAPIES, INC. Financials
finance.yahoo.com - December 8 at 1:18 PM
finance.yahoo.com logoBioRestorative Therapies, Inc. Announces Opening of New Headquarters and Laboratory Facility in New York
finance.yahoo.com - April 14 at 7:45 AM
finance.yahoo.com logoBioRestorative Therapies Appoints Charles S. Ryan, J.D., Ph.D. to its Board of Directors
finance.yahoo.com - April 8 at 8:52 AM

Social

Chart

BioRestorative Therapies (BRTX) Chart for Sunday, September, 24, 2017

This page was last updated on 9/24/2017 by MarketBeat.com Staff